Status:
UNKNOWN
Tamoxifen Compared With Clomiphene Citrate for Women Who Had Thin Endometrium Women Under Clomiphene in a Previous Cycle
Lead Sponsor:
Shaare Zedek Medical Center
Conditions:
Infertility
Eligibility:
FEMALE
18-35 years
Phase:
NA
Brief Summary
About 10-15% of all couples attempting to conceive will not become pregnant within one year. Among those, the majority will have ovulatory dysfunction, mild male infertility or unexplained infertility...
Eligibility Criteria
Inclusion
- Primary or secondary infertility due to:
- Ovulatory dysfunction
- Mild male infertility
- Unexplained infertility
- Endometrium \< 6 mm at time of hCG during previous treatment with clomiphene citrate
- Age 18-35
Exclusion
- Serious adverse effects under clomiphene citrate or known sensitivity to either tamoxifen or clomiphene citrate
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00449514
Start Date
May 1 2007
Last Update
September 20 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shaare-Zedek Medical Center
Jerusalem, Israel